the mecholyl challenge test is commonly used to diagnose bronchial hyperresponsiveness.
美可洛尔激发试验常用于诊断支气管高反应性。
patients with asthma often show increased mecholyl sensitivity.
哮喘患者通常表现出美可洛尔敏感性增加。
the mecholyl inhalation test measures airway responsiveness to specific stimuli.
美可洛尔吸入试验测量气道对特定刺激的反应性。
a positive mecholyl response indicates underlying airway inflammation.
美可洛尔反应阳性提示存在潜在的气道炎症。
the mecholyl dose is carefully calculated based on patient weight and medical history.
美可洛尔剂量根据患者体重和病史仔细计算。
mecholyl-induced bronchoconstriction can be reversed with appropriate bronchodilator medication.
美可洛尔诱导的支气管收缩可用适当的支气管扩张剂药物逆转。
healthcare providers closely monitor patients during mecholyl challenge procedures for safety.
医疗人员在美可洛尔激发试验过程中密切监测患者以确保安全。
mecholyl testing helps physicians differentiate asthma from other respiratory conditions with similar symptoms.
美可洛尔试验帮助医生区分哮喘与其他具有相似症状的呼吸系统疾病。
the mecholyl provocation test should only be performed in specialized medical facilities with emergency equipment available.
美可洛尔激发试验应在配备急救设备的专门医疗机构进行。
some individuals exhibit heightened mecholyl reactivity without displaying any clinical symptoms of respiratory disease.
一些个体表现出升高的美可洛尔反应性，却未显示任何呼吸道疾病的临床症状。
baseline lung function measurements must be established before mecholyl administration begins.
在开始使用美可洛尔之前，必须建立基线肺功能测量值。
mecholyl chloride is the pharmaceutical formulation commonly used in clinical bronchial challenge testing.
氯化美可洛尔是临床支气管激发试验中常用的药物制剂。
the standardized mecholyl challenge protocol follows international guidelines for respiratory diagnosis.
标准化的美可洛尔激发方案遵循国际呼吸系统诊断指南。
patients are typically advised to avoid bronchodilators and antihistamines before mecholyl testing.
通常建议患者在美可洛尔测试前避免使用支气管扩张剂和抗组胺药。
severe reactions to mecholyl require immediate medical intervention and respiratory support if necessary.
对美可洛尔的严重反应需要立即进行医疗干预，必要时提供呼吸支持。
the mecholyl challenge test is commonly used to diagnose bronchial hyperresponsiveness.
美可洛尔激发试验常用于诊断支气管高反应性。
patients with asthma often show increased mecholyl sensitivity.
哮喘患者通常表现出美可洛尔敏感性增加。
the mecholyl inhalation test measures airway responsiveness to specific stimuli.
美可洛尔吸入试验测量气道对特定刺激的反应性。
a positive mecholyl response indicates underlying airway inflammation.
美可洛尔反应阳性提示存在潜在的气道炎症。
the mecholyl dose is carefully calculated based on patient weight and medical history.
美可洛尔剂量根据患者体重和病史仔细计算。
mecholyl-induced bronchoconstriction can be reversed with appropriate bronchodilator medication.
美可洛尔诱导的支气管收缩可用适当的支气管扩张剂药物逆转。
healthcare providers closely monitor patients during mecholyl challenge procedures for safety.
医疗人员在美可洛尔激发试验过程中密切监测患者以确保安全。
mecholyl testing helps physicians differentiate asthma from other respiratory conditions with similar symptoms.
美可洛尔试验帮助医生区分哮喘与其他具有相似症状的呼吸系统疾病。
the mecholyl provocation test should only be performed in specialized medical facilities with emergency equipment available.
美可洛尔激发试验应在配备急救设备的专门医疗机构进行。
some individuals exhibit heightened mecholyl reactivity without displaying any clinical symptoms of respiratory disease.
一些个体表现出升高的美可洛尔反应性，却未显示任何呼吸道疾病的临床症状。
baseline lung function measurements must be established before mecholyl administration begins.
在开始使用美可洛尔之前，必须建立基线肺功能测量值。
mecholyl chloride is the pharmaceutical formulation commonly used in clinical bronchial challenge testing.
氯化美可洛尔是临床支气管激发试验中常用的药物制剂。
the standardized mecholyl challenge protocol follows international guidelines for respiratory diagnosis.
标准化的美可洛尔激发方案遵循国际呼吸系统诊断指南。
patients are typically advised to avoid bronchodilators and antihistamines before mecholyl testing.
通常建议患者在美可洛尔测试前避免使用支气管扩张剂和抗组胺药。
severe reactions to mecholyl require immediate medical intervention and respiratory support if necessary.
对美可洛尔的严重反应需要立即进行医疗干预，必要时提供呼吸支持。
探索常用高频词汇